Tuesday, August 08, 2023 10:14:12 PM
Assuming the company is intentionally leaving us in the dark, wouldn't that go against their fiduciary duties? Let's assume they have already submitted month(s) ago, but the next 10q on Aug 14th states that they are still in the process of finalizing. Wouldn't that be a bit of a smack to the face on investors?
Granted, things could be much further along in the process without submission happening, but this potential information of progress would be beneficial to us as the timeline has dragged on longer than what was anticipated.
I see two scenarios:
1.) (UNLIKLEY): NWBO is farther along than what is currently known. Submission could have happened already. Thermo's and Les's remarks was made to throw off nefarious forces. Acceptance and/or approval is in the works. (Canadian Drug Bank's update back in March may add some small credibility to this theory.)
2.) (LIKLEY): NWBO has not yet submitted. Les's talk on the Big Show and Thermo's comments hold merit on filings being finalized still, and the Canadian Drug Bank's update was just a routine manner for anticipated drugs coming out of Phase 3 trails that may or may not get regulatory approval (my assumption).
Hoping we are all surprised with approval news (or something in between), but IMO, it's looking as if we are still waiting on submission. Aug 14th's 10q will tell us more hopefully.
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM